scholarly article | Q13442814 |
P356 | DOI | 10.1002/BTPR.1842 |
P698 | PubMed publication ID | 24265112 |
P50 | author | Yusuf Chisti | Q47336311 |
Francisco Garcia-Camacho | Q73323731 | ||
Asterio Sánchez Mirón | Q39472419 | ||
Emilio Molina Grima | Q39472450 | ||
P2093 | author name string | A Contreras-Gómez | |
P2860 | cites work | Production of Human Beta Interferon in Insect Cells Infected with a Baculovirus Expression Vector | Q24604122 |
Actin in herpesvirus infection | Q26823346 | ||
How HIV takes advantage of the cytoskeleton in entry and replication | Q27021639 | ||
Silkworm expression system as a platform technology in life science | Q27490782 | ||
Downstream processing of monoclonal antibodies--application of platform approaches | Q28268820 | ||
The establishment of two cell lines from the insectspodoptera frugiperda (lepidoptera; noctuidae) | Q28275475 | ||
Activation of PI3K/AKT and ERK MAPK signal pathways is required for the induction of lytic cycle replication of Kaposi's sarcoma-associated herpesvirus by herpes simplex virus type 1 | Q28393661 | ||
Immunogenicity and safety of virus-like particle of the porcine encephalomyocarditis virus in pig | Q28743371 | ||
Principles of CDK regulation | Q29547820 | ||
A fast track influenza virus vaccine produced in insect cells | Q30226454 | ||
Safety and immunogenicity of a virus-like particle pandemic influenza A (H1N1) 2009 vaccine in a blinded, randomized, placebo-controlled trial of adults in Mexico | Q30405652 | ||
Metabolic and kinetic analyses of influenza production in perfusion HEK293 cell culture | Q30406617 | ||
Recombinant protein vaccines produced in insect cells | Q30412076 | ||
Population kinetics during simultaneous infection of insect cells with two different recombinant baculoviruses for the production of rotavirus-like particles | Q33289922 | ||
Baculovirus phylogeny and evolution | Q33304854 | ||
Identification of the lymantria dispar nucleopolyhedrovirus envelope fusion protein provides evidence for a phylogenetic division of the Baculoviridae | Q33806997 | ||
Hybrid metabolic flux analysis: combining stoichiometric and statistical constraints to model the formation of complex recombinant products | Q33830114 | ||
Safety and efficacy of a recombinant hepatitis E vaccine | Q34002701 | ||
Animal-cell damage in sparged bioreactors | Q34040109 | ||
Quantitative proteomics of Spodoptera frugiperda cells during growth and baculovirus infection. | Q34062438 | ||
Evaluation of a disposable stirred tank bioreactor for cultivation of mammalian cells | Q34175346 | ||
Expression-system-dependent modulation of HIV-1 envelope glycoprotein antigenicity and immunogenicity | Q34175370 | ||
Insect cells as factories for biomanufacturing | Q34222558 | ||
SweetBac: a new approach for the production of mammalianised glycoproteins in insect cells. | Q34224840 | ||
Dynamic interactions between Bombyx mori nucleopolyhedrovirus and its host cells revealed by transcriptome analysis | Q34244826 | ||
Screening of insect cell lines for the production of recombinant proteins and infectious virus in the baculovirus expression system | Q34247472 | ||
Establishment of four strains of cells from insect tissues grown in vitro | Q34252278 | ||
BM61 of Bombyx mori nucleopolyhedrovirus: its involvement in the egress of nucleocapsids from the nucleus | Q34262550 | ||
Inhibition of ICE family proteases by baculovirus antiapoptotic protein p35. | Q34296405 | ||
High cell density fed batch and perfusion processes for stable non-viral expression of secreted alkaline phosphatase (SEAP) using insect cells: comparison to a batch Sf-9-BEV system | Q40217580 | ||
Retroviral vector production using suspension-adapted 293GPG cells in a 3L acoustic filter-based perfusion bioreactor | Q40237124 | ||
Effect of conditioned medium factors on productivity and cell physiology in Trichoplusia ni insect cell cultures | Q40273050 | ||
Effects of conditioned medium factors and passage number on Sf9 cell physiology and productivity | Q40295034 | ||
Quantitative studies of cell-bubble interactions and cell damage at different pluronic F-68 and cell concentrations | Q40528232 | ||
An additional copy of the homologous region (hr1) sequence in the Autographa californica multinucleocapsid polyhedrosis virus genome promotes hyperexpression of foreign genes | Q40542982 | ||
Spontaneous excision of BAC vector sequences from bacmid-derived baculovirus expression vectors upon passage in insect cells | Q40550219 | ||
Enhancement of correct protein folding in vivo by a non-lytic baculovirus | Q40555895 | ||
Scale-up of virus-like particles production: effects of sparging, agitation and bioreactor scale on cell growth, infection kinetics and productivity. | Q40605464 | ||
Production of a sialylated N-linked glycoprotein in insect cells: role of glycosidases and effect of harvest time on glycosylation | Q40672323 | ||
Optimization of an acoustic cell filter with a novel air-backflush system | Q40672401 | ||
Optimization of a feed medium for fed-batch culture of insect cells using a genetic algorithm | Q40684378 | ||
Microcarrier culture of lepidopteran cell lines: implications for growth and recombinant protein production | Q40685365 | ||
The effect of dissolved oxygen (DO) concentration on the glycosylation of recombinant protein produced by the insect cell-baculovirus expression system | Q40761312 | ||
Engineering lepidopteran insect cells for sialoglycoprotein production by genetic transformation with mammalian beta 1,4-galactosyltransferase and alpha 2,6-sialyltransferase genes | Q40826999 | ||
Expression and characterization of recombinant human alpha-3/4-fucosyltransferase III from Spodoptera frugiperda (Sf9) and Trichoplusia ni (Tn) cells using the baculovirus expression system | Q40828310 | ||
Cell cycle progression in serum-free cultures of Sf9 insect cells: modulation by conditioned medium factors and implications for proliferation and productivity | Q40850036 | ||
Plant protein hydrolysates: preparation of defined peptide fractions promoting growth and production in animal cells cultures | Q40850104 | ||
Manipulation of baculovirus vectors | Q40872350 | ||
Filamentous actin is required for lepidopteran nucleopolyhedrovirus progeny production | Q40873126 | ||
Adaptation of an insect cell line of Spodoptera frugiperda to grow at 37 degrees C: characterization of an endodiploid clone | Q40893724 | ||
Optimising fed-batch production of recombinant proteins using the baculovirus expression vector system | Q40963459 | ||
Low-cost serum-free medium for the BTI-Tn5B1-4 insect cell line | Q41018907 | ||
Stable expression of mammalian beta 1,4-galactosyltransferase extends the N-glycosylation pathway in insect cells. | Q41041039 | ||
Autographa californica nucleopolyhedrovirus infection results in Sf9 cell cycle arrest at G2/M phase | Q41044319 | ||
Effect of elevated oxygen and glutamine levels on foreign protein production at high cell densities using the insect cell-baculovirus expression system | Q41115327 | ||
Toward system-level understanding of baculovirus-host cell interactions: from molecular fundamental studies to large-scale proteomics approaches | Q41301287 | ||
Optimization of the growth conditions of Sf21 insect cells for high-density perfusion culture in stirred-tank bioreactors | Q41465927 | ||
Relationship between oxygen uptake rate and time of infection of Sf9 insect cells infected with a recombinant baculovirus | Q41505067 | ||
Maximization of recombinant protein yield in the insect cell/baculovirus system by one-time addition of nutrients to high-density batch cultures | Q41505086 | ||
Growth, nutrient consumption, and end-product accumulation in Sf-9 and BTI-EAA insect cell cultures: insights into growth limitation and metabolism | Q41518929 | ||
Fed-batch culture of insect cells: a method to increase the yield of recombinant human nerve growth factor (rhNGF) in the baculovirus expression system | Q41518945 | ||
Effect of temperature and oxygen on cell growth and recombinant protein production in insect cell cultures | Q41577274 | ||
Effects of oxygen on recombinant protein production by suspension cultures of Spodoptera frugiperda (Sf-9) insect cells | Q41601374 | ||
Microscopic visualization of insect cell-bubble interactions. II: The bubble film and bubble rupture | Q41694656 | ||
Microscopic visualization of insect cell-bubble interactions. I: Rising bubbles, air-medium interface, and the foam layer | Q41694662 | ||
Improvement of the yields of recombinant actin and myosin V-HMM in the insect cell/baculovirus system by the addition of nutrients to the high-density cell culture | Q42011529 | ||
Simultaneous expression of recombinant proteins in the insect cell-baculovirus system: production of virus-like particles. | Q42014317 | ||
Downstream processing of triple layered rotavirus like particles | Q42036130 | ||
Triple layered rotavirus VLP production: kinetics of vector replication, mRNA stability and recombinant protein production. | Q42040378 | ||
A mathematical model of baculovirus infection on insect cells at low multiplicity of infection | Q42043309 | ||
Human interleukin-2 production in insect (Trichoplusia ni) larvae: effects and partial control of proteolysis | Q42058939 | ||
Heterologous protein expression affects the death kinetics of baculovirus-infected insect cell cultures: a quantitative study by use of n-target theory | Q42069197 | ||
Establishment of a line of cells from the silkworm Bombyx mori | Q42081920 | ||
Baculovirus: molecular insights on their diversity and conservation. | Q42766520 | ||
Established insect cell line from the cabbage looper, Trichoplusia ni. | Q42802937 | ||
Analysis of adsorption of a baculovirus bioreaction bulk on an ion-exchange surface by surface plasmon resonance. | Q43010646 | ||
Using cell size kinetics to determine optimal harvest time for Spodoptera frugiperda and Trichoplusia ni BTI-TN-5B1-4 cells infected with a baculovirus expression vector system expressing enhanced green fluorescent protein | Q43076259 | ||
Modeling protein binding and elution over a chromatographic surface probed by surface plasmon resonance | Q43155872 | ||
An initiative to manufacture and characterize baculovirus reference material | Q43704529 | ||
Production of a sialylated N-linked glycoprotein in insect cells | Q43757068 | ||
Strategies for improved dCO2 removal in large-scale fed-batch cultures | Q44305849 | ||
Goose parvovirus structural proteins expressed by recombinant baculoviruses self-assemble into virus-like particles with strong immunogenicity in goose | Q44413898 | ||
Purification of cell culture-derived human influenza A virus by size-exclusion and anion-exchange chromatography | Q45412901 | ||
Improving adeno-associated vector yield in high density insect cell cultures | Q45856539 | ||
Modeling the population dynamics of baculovirus-infected insect cells: Optimizing infection strategies for enhanced recombinant protein yields | Q46624519 | ||
Dissolved carbon dioxide accumulation in a large scale and high density production of TGFβ receptor with baculovirus infected Sf-9 cells | Q47744407 | ||
Economics of baculovirus-insect cell production systems | Q47745339 | ||
On-line monitoring of respiration in recombinant-baculovirus infected and uninfected insect cell bioreactor cultures | Q47863821 | ||
Low multiplicity infection of insect cells with a recombinant baculovirus: The cell yield concept | Q47863857 | ||
Baculovirus expression system scaleup by perfusion of high-density Sf-9 cell cultures | Q47866521 | ||
Production of recombinant proteins in high-density insect cell cultures | Q47867286 | ||
High-level recombinant protein production in bioreactors using the baculovirus-insect cell expression system | Q47869575 | ||
GAD65 vaccination: 5 years of follow-up in a randomised dose-escalating study in adult-onset autoimmune diabetes | Q47912616 | ||
Effects of oxygen on recombinant protein expression | Q47986197 | ||
An efficient expression system for the production of functionally active human LKB1. | Q51564823 | ||
Overcoming challenges in WAVE Bioreactors without feedback controls for pH and dissolved oxygen. | Q51764595 | ||
Continuous production of baculovirus in a cascade of insect-cell reactors. | Q52441833 | ||
Assembly of feline calicivirus-like particle and its immunogenicity. | Q52674524 | ||
The effect of dissolved oxygen tension and the utility of oxygen uptake rate in insect cell culture. | Q52734554 | ||
Human herpesvirus 6A infects human embryonic fibroblasts and induces G2/M arrest and cell death. | Q54323994 | ||
Anion-exchange membrane chromatography for purification of rotavirus-like particles | Q57774962 | ||
Hydrodynamic damage to animal cells. | Q34307322 | ||
Characterization of v-cath, a cathepsin L-like proteinase expressed by the baculovirus Autographa californica multiple nuclear polyhedrosis virus | Q34309370 | ||
Baculovirus as versatile vectors for protein expression in insect and mammalian cells | Q34416430 | ||
Baculoviruses-- re-emerging biopesticides. | Q34463744 | ||
Stability of serum-free and purified baculovirus stocks under various storage conditions | Q34490884 | ||
On the classification and nomenclature of baculoviruses: a proposal for revision | Q34519539 | ||
Effective chikungunya virus-like particle vaccine produced in insect cells | Q34630576 | ||
Selecting an appropriate method for expressing a recombinant protein | Q35011411 | ||
Potential of cell retention techniques for large-scale high-density perfusion culture of suspended mammalian cells | Q35109829 | ||
Insect cell culture for industrial production of recombinant proteins. | Q35122202 | ||
Safety and immunogenicity of a candidate parvovirus B19 vaccine | Q35268947 | ||
Baculovirus infection induces a DNA damage response that is required for efficient viral replication | Q35531444 | ||
A new glycoengineered insect cell line with an inducibly mammalianized protein N-glycosylation pathway. | Q35703121 | ||
Equipment design considerations for large scale cell culture | Q36254691 | ||
Promoting effect of rapeseed proteins and peptides on Sf9 insect cell growth | Q36255209 | ||
Culture in vitro of tissue from the silkworm, Bombyx mori L. | Q36287083 | ||
Innovative use of a bacterial enzyme involved in sialic acid degradation to initiate sialic acid biosynthesis in glycoengineered insect cells | Q36392872 | ||
Characterization of yeastolate fractions that promote insect cell growth and recombinant protein production | Q36495654 | ||
Polydnavirus genes that enhance the baculovirus expression vector system | Q36601819 | ||
Protein N-glycosylation in the baculovirus-insect cell expression system and engineering of insect cells to produce "mammalianized" recombinant glycoproteins. | Q36601827 | ||
Baculovirus: an insect-derived vector for diverse gene transfer applications | Q36740261 | ||
Protein N-glycosylation in the baculovirus-insect cell system. | Q36990066 | ||
Baculoviral vectors for gene delivery: a review | Q37108340 | ||
Protection against lethal challenge by Ebola virus-like particles produced in insect cells | Q37131622 | ||
Viral manipulation of DNA repair and cell cycle checkpoints | Q37301053 | ||
Safety and immunogenicity of BPV-1 L1 virus-like particles in a dose-escalation vaccination trial in horses | Q37612161 | ||
Baculovirus-insect cell expression systems. | Q37628072 | ||
Disposable bioreactors: the current state-of-the-art and recommended applications in biotechnology | Q37679732 | ||
Bioprocessing of baculovirus vectors: a review | Q37728068 | ||
Virus-like particles in vaccine development. | Q37798008 | ||
Robots, pipelines, polyproteins: enabling multiprotein expression in prokaryotic and eukaryotic cells | Q37855049 | ||
Arbovirus vaccines; opportunities for the baculovirus-insect cell expression system | Q37904374 | ||
Opportunities and challenges for the baculovirus expression system | Q37904377 | ||
Large-scale production and purification of VLP-based vaccines | Q37904378 | ||
Baculovirus as vectors for human cells and applications in organ transplantation | Q37904380 | ||
Latest developments in the large-scale production of adeno-associated virus vectors in insect cells toward the treatment of neuromuscular diseases | Q37904385 | ||
Quality control and analytical methods for baculovirus-based products | Q37904387 | ||
Insect cell technology is a versatile and robust vaccine manufacturing platform | Q37909427 | ||
Application of baculovirus-insect cell expression system for human therapy. | Q37929233 | ||
Optimizing the baculovirus expression vector system | Q37938335 | ||
Quality attributes of recombinant therapeutic proteins: an assessment of impact on safety and efficacy as part of a quality by design development approach | Q37999739 | ||
Baculovirus genes modulating intracellular innate antiviral immunity of lepidopteran insect cells. | Q38065389 | ||
Recent advances in bioprocessing application of membrane chromatography | Q38077353 | ||
Use of baculovirus expression system for generation of virus-like particles: successes and challenges | Q38112493 | ||
Safety and immunogenicity of a baculovirus-expressed hemagglutinin influenza vaccine: a randomized controlled trial | Q38398137 | ||
Adaptation of the Se301 insect cell line to suspension culture. Effect of turbulence on growth and on production of nucleopolyhedrovius (SeMNPV). | Q39136240 | ||
Adaptation of the Spodoptera exigua Se301 insect cell line to grow in serum-free suspended culture. Comparison of SeMNPV productivity in serum-free and serum-containing media. | Q39236933 | ||
Purification of a recombinant baculovirus of Autographa californica M nucleopolyhedrovirus by ion exchange membrane chromatography | Q39361335 | ||
An integrated analysis of enzyme activities, cofactor pools and metabolic fluxes in baculovirus-infected Spodoptera frugiperda Sf9 cells | Q39646399 | ||
Improving baculovirus production at high cell density through manipulation of energy metabolism | Q39803264 | ||
Enhancing the multiplication of nucleopolyhedrovirus in vitro by manipulation of the pH. | Q39829484 | ||
The role of the PI3K-Akt signal transduction pathway in Autographa californica multiple nucleopolyhedrovirus infection of Spodoptera frugiperda cells | Q39829964 | ||
Optimization of chimeric HIV-1 virus-like particle production in a baculovirus-insect cell expression system | Q39830189 | ||
Cell density effect in the baculovirus-insect cells system: a quantitative analysis of energetic metabolism | Q39848656 | ||
Purification of recombinant baculoviruses for gene therapy using membrane processes. | Q39865115 | ||
Synthesis of empty capsid-like particles of Asia I foot-and-mouth disease virus in insect cells and their immunogenicity in guinea pigs | Q39891157 | ||
Rapid high-performance liquid chromatographic analysis of adenovirus type 5 particles with a prototype anion-exchange analytical monolith column. | Q39911090 | ||
Baculovirus production for gene therapy: the role of cell density, multiplicity of infection and medium exchange | Q39928735 | ||
In situ 2D fluorometry and chemometric monitoring of mammalian cell cultures. | Q39929606 | ||
Comparison of Trichoplusia ni BTI-Tn-5B1-4 (high five) and Spodoptera frugiperda Sf-9 insect cell line metabolism in suspension cultures | Q39959857 | ||
Virus production for clinical gene therapy | Q39966673 | ||
Targeting and purification of metabolically biotinylated baculovirus | Q39982595 | ||
Disposable bioprocessing: the future has arrived | Q40017701 | ||
Production of baculovirus-expressed recombinant proteins in wave bioreactors | Q40064328 | ||
Development of serum-free media for lepidopteran insect cell lines | Q40064349 | ||
High yield purification of functional baculovirus vectors by size exclusion chromatography | Q40170028 | ||
Improving AAV vector yield in insect cells by modulating the temperature after infection. | Q40175483 | ||
P433 | issue | 1 | |
P921 | main subject | insect | Q1390 |
P304 | page(s) | 1-18 | |
P577 | publication date | 2014-01-01 | |
P1433 | published in | Biotechnology Progress | Q15753227 |
P1476 | title | Protein production using the baculovirus-insect cell expression system | |
P478 | volume | 30 |
Q61800268 | A Brief Reminder of Systems of Production and Chromatography-Based Recovery of Recombinant Protein Biopharmaceuticals |
Q98162456 | A vaccine targeting the RBD of the S protein of SARS-CoV-2 induces protective immunity |
Q39394355 | Advances in the development of human protein microarrays. |
Q47407694 | Adventitious viruses in insect cell lines used for recombinant protein expression |
Q40118467 | An N-terminal Pfs230 domain produced in baculovirus as a biological active transmission-blocking vaccine candidate |
Q38311304 | Baculoviruses and nucleosome management |
Q38749484 | Crystallization of Membrane Proteins: An Overview |
Q90040198 | Development of a Combined Genetic Engineering Vaccine for Porcine Circovirus Type 2 and Mycoplasma Hyopneumoniae by a Baculovirus Expression System |
Q38822411 | Engineering the transposition-based baculovirus expression vector system for higher efficiency protein production from insect cells |
Q93056756 | Expression and purification optimization of an N-terminal Pfs230 transmission-blocking vaccine candidate |
Q90102138 | Expression of Recombinant PfCelTOS Antigen in the Chloroplast of Chlamydomonas reinhardtii and its Potential Use in Detection of Malaria |
Q40049122 | Expression of the lef5 gene from Spodoptera exigua multiple nucleopolyhedrovirus contributes to the baculovirus stability in cell culture. |
Q33692210 | Expression, purification and structural analysis of functional GABA transporter 1 using the baculovirus expression system |
Q30367871 | Functional expression of the 11 human Organic Anion Transporting Polypeptides in insect cells reveals that sodium fluorescein is a general OATP substrate. |
Q36659566 | High Yield Expression of Recombinant Human Proteins with the Transient Transfection of HEK293 Cells in Suspension |
Q39030574 | Highly efficient expression of functional recombinant human keratinocyte growth factor 1 and its protective effects on hepatocytes |
Q40158347 | Improving the baculovirus expression vector system with vankyrin-enhanced technology |
Q42102335 | Incorporation of Heterologous Proteins in Engineered Exosomes. |
Q26767368 | Manufacturing of AcMNPV baculovirus vectors to enable gene therapy trials |
Q59353382 | Modifying Baculovirus Expression Vectors to Produce Secreted Plant Proteins in Insect Cells |
Q93019048 | Oral administration of porcine epidemic diarrhea virus spike protein expressing in silkworm pupae failed to elicit immune responses in pigs |
Q52717516 | Production and Purification of Baculovirus for Gene Therapy Application. |
Q37481526 | Purification of baculovirus vectors using heparin affinity chromatography |
Q41000237 | Real-time direct cell concentration and viability determination using a fully automated microfluidic platform for standalone process monitoring |
Q92542772 | Recent Developments in Bioprocessing of Recombinant Proteins: Expression Hosts and Process Development |
Q57462280 | Screening of candidate substrates and coupling ions of transporters by thermostability shift assays |
Q53077203 | Selectable high-yield recombinant protein production in human cells using a GFP/YFP nanobody affinity support. |
Q50227807 | Small Molecule Approach to Study the Function of Mitotic Kinesins |
Q41046189 | Small Molecule Inhibitors Targeting Tec Kinase Block Unconventional Secretion of Fibroblast Growth Factor 2 |
Q38831288 | The MultiBac Baculovirus/Insect Cell Expression Vector System for Producing Complex Protein Biologics |
Q34090835 | The recombinant expression systems for structure determination of eukaryotic membrane proteins |
Q40105788 | The use of an artificial neural network to model the infection strategy for baculovirus production in suspended insect cell cultures |
Q38705869 | Transient Expression and Cellular Localization of Recombinant Proteins in Cultured Insect Cells. |
Q38243160 | Update on baculovirus as an expression and/or delivery vehicle for vaccine antigens |
Q36187992 | Utilizing the virus-induced blocking of apoptosis in an easy baculovirus titration method |
Search more.